Page last updated: 2024-10-24

N-formyl peptide receptor activity

Definition

Target type: molecularfunction

Combining with an N-formyl peptide to initiate a change in cell activity. [GOC:ai]

N-formyl peptide receptor activity is a crucial molecular function in innate immunity, particularly in the detection and response to bacterial infections. It involves the recognition and binding of N-formyl peptides, which are small peptides containing a formyl group at their N-terminus. These peptides are primarily found in bacteria and are absent in mammalian cells, making them unique markers of bacterial presence. N-formyl peptide receptors (FPRs) are a family of G protein-coupled receptors (GPCRs) that exhibit high affinity for N-formyl peptides. Upon binding, these receptors activate a signaling cascade involving the heterotrimeric G protein, leading to the production of intracellular signaling molecules like inositol triphosphate (IP3) and diacylglycerol (DAG). This triggers a series of downstream events, including the mobilization of intracellular calcium, activation of protein kinase C (PKC), and the production of reactive oxygen species (ROS). These events contribute to the host's immune response by promoting leukocyte chemotaxis, phagocytosis, and the release of inflammatory mediators. The overall effect of N-formyl peptide receptor activity is to enhance the recruitment of immune cells to the site of infection, facilitating the clearance of bacteria and the resolution of inflammation.'
"

Proteins (2)

ProteinDefinitionTaxonomy
N-formyl peptide receptor 2An N-formyl peptide receptor 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P25090]Homo sapiens (human)
fMet-Leu-Phe receptorAn fMet-Leu-Phe receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:P21462]Homo sapiens (human)

Compounds (8)

CompoundDefinitionClassesRoles
sulfinpyrazoneSulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.pyrazolidines;
sulfoxide
uricosuric drug
formylmethionyl-leucyl-phenylalanine methyl esterpeptide
butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalaninebutyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine: formyl peptide antagonist and lipoxin A4 receptor antagonist
n-formylmethionine leucyl-phenylalanineN-formyl-L-methionyl-L-leucyl-L-phenylalanine : A tripeptide composed of L-Met, L-Leu and L-Phe in a linear sequence with a formyl group at the amino terminus. It acts as a potent inducer of leucocyte chemotaxis and macrophage activator as well as a ligand for the FPR receptor.

N-Formylmethionine Leucyl-Phenylalanine: A formylated tripeptide originally isolated from bacterial filtrates that is positively chemotactic to polymorphonuclear leucocytes, and causes them to release lysosomal enzymes and become metabolically activated.
tripeptide
acetic acid [6-ethyl-2-methyl-3-(1-methyl-2-benzimidazolyl)-4-oxo-1-benzopyran-7-yl] esterchromones
lipoxin a4lipoxin A4 : A C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.

lipoxin A4: an antifibrolytic agent; structure given in first source; a role in ASPIRIN antiinflammatory activity
hydroxy polyunsaturated fatty acid;
lipoxin;
long-chain fatty acid
human metabolite;
metabolite
cyclosporineramihyphin A: one of the metabolites produced by Fusarium sp. S-435; RN given refers to cpd with unknown MFhomodetic cyclic peptideanti-asthmatic drug;
anticoronaviral agent;
antifungal agent;
antirheumatic drug;
carcinogenic agent;
dermatologic drug;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
geroprotector;
immunosuppressive agent;
metabolite
trp-lys-tyr-met-val-metTrp-Lys-Tyr-Met-Val-Met: a synthetic peptide, stimulates phosphoinositide hyrolysis in human leukocytes